Syngene International Ltd Technical Analysis Reveals Mixed Momentum Amid Bearish Shift

Technical Momentum and Price Action Overview

As of 25 May 2026, Syngene International’s stock price closed at ₹461.75, down 1.81% from the previous close of ₹470.25. The intraday range was relatively narrow, with a low of ₹460.65 and a high of ₹472.00. This price action comes against a backdrop of a 52-week high of ₹728.40 and a low of ₹380.00, indicating the stock remains closer to its lower range over the past year.

The technical trend has shifted from a sideways pattern to mildly bearish, signalling a potential weakening in price momentum. This shift is corroborated by the daily moving averages, which currently indicate a mildly bearish stance. The stock’s recent price behaviour suggests that short-term selling pressure is increasing, although not yet at a level to confirm a strong downtrend.

MACD and RSI: Divergent Signals

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD remains mildly bullish, suggesting some underlying positive momentum in the medium term. However, the monthly MACD is bearish, indicating that longer-term momentum is weakening. This divergence between weekly and monthly MACD readings highlights the stock’s current technical uncertainty.

Relative Strength Index (RSI) readings for both weekly and monthly periods show no clear signal, hovering in neutral zones. This lack of directional RSI momentum suggests that the stock is neither overbought nor oversold, reinforcing the notion of a consolidating or uncertain trend.

Bollinger Bands and KST Indicators

Bollinger Bands add further complexity to the technical outlook. Weekly Bollinger Bands are bullish, implying that the stock price is trading near the upper band and may experience upward pressure in the short term. Conversely, monthly Bollinger Bands are bearish, signalling potential downside risk over a longer horizon.

The Know Sure Thing (KST) indicator aligns with this mixed view: mildly bullish on the weekly chart but bearish on the monthly chart. This again points to a short-term positive momentum that is not yet supported by longer-term strength.

Volume and Trend Confirmation

On-Balance Volume (OBV) readings are bullish on both weekly and monthly timeframes, indicating that volume trends support the recent price movements. This suggests accumulation by investors despite the price softness, which could be a positive sign if confirmed by price strength in coming sessions.

However, Dow Theory analysis shows no clear trend on either weekly or monthly charts, underscoring the absence of a definitive directional bias in the broader market context for this stock.

Comparative Performance and Market Context

Syngene International’s recent returns have lagged behind the Sensex benchmark across multiple timeframes. Over the past week, the stock gained 1.63%, outperforming the Sensex’s 0.24% rise. However, over one month, the stock’s 5.94% gain contrasts with a 3.95% decline in the Sensex, showing some short-term resilience.

Year-to-date, the stock has declined by 29.06%, significantly underperforming the Sensex’s 11.51% fall. Over one and three years, the stock’s returns of -27.45% and -33.98% respectively starkly contrast with the Sensex’s positive returns of 6.84% and 21.71%. Even over five years, Syngene’s -19.14% return trails the Sensex’s 49.22% gain. Only over a decade has the stock delivered a strong cumulative return of 140.65%, though still below the Sensex’s 198.06%.

Mojo Score and Ratings Update

MarketsMOJO assigns Syngene International a Mojo Score of 42.0, reflecting a cautious stance. The Mojo Grade has been downgraded from Strong Sell to Sell as of 16 April 2026, signalling a slight improvement but still indicating weak technical and fundamental conditions. The company is classified as a small-cap within the Healthcare Services sector, which often entails higher volatility and risk.

This downgrade suggests that while some technical indicators show mild bullishness, the overall outlook remains negative, and investors should approach with caution. The mixed signals from various technical tools reinforce the need for careful monitoring of price action and volume trends before committing to a position.

Moving Averages and Daily Technicals

Daily moving averages currently indicate a mildly bearish trend, with short-term averages likely trading below longer-term averages. This alignment typically suggests that recent price momentum is weakening. Traders often view such signals as a warning of potential further downside unless reversed by strong buying interest.

Given the daily moving averages’ bearish tilt, short-term traders may consider tighter stops or reduced exposure until clearer bullish confirmation emerges.

Investment Implications and Outlook

Syngene International’s technical profile is characterised by a tug-of-war between short-term bullish signals and longer-term bearish momentum. Weekly indicators such as MACD, Bollinger Bands, KST, and OBV show some positive undercurrents, but monthly indicators remain bearish or neutral, reflecting underlying weakness.

Investors should weigh these mixed signals carefully. The stock’s significant underperformance relative to the Sensex over multiple timeframes highlights challenges in regaining investor confidence. However, the bullish volume trends and weekly momentum indicators suggest that a base could be forming, potentially setting the stage for a recovery if supported by fundamental catalysts.

In conclusion, Syngene International Ltd’s current technical parameters suggest a cautious stance for investors. While short-term momentum indicators offer some optimism, the prevailing monthly bearish signals and underwhelming relative performance warrant prudence. Monitoring key support levels near ₹460 and observing any shifts in volume and moving averages will be critical in assessing whether the stock can regain upward momentum.

For investors with a higher risk tolerance, selective accumulation on dips could be considered, but only with strict risk management given the mixed technical backdrop. Those seeking more stable or outperforming opportunities may find better prospects elsewhere within the Healthcare Services sector or broader market.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →